Therapeutic Method [topp]
Patients [podg]
Eisenmenger Syndrome [cgab, dsyn]
Patients [podg]
Eisenmenger Syndrome [cgab, dsyn]
Form [qlco]
Small [qnco]
Percentage [qnco]
Congenital heart disease [cgab, dsyn]
Patients [podg]
Rare [tmco]
Syndrome [dsyn]
Combined [qlco]
Complex [qlco]
pathophysiology [ftcn]
account [idcn]
Insufficient [qlco]
Understanding [menp]
treatment [ftcn]
Main [qlco]
symptoms [ftcn]
Cyanosis [sosy]
Secondary erythrocytosis [dsyn]
Increased blood viscosity [fndg]
Iron deficiency anaemia [dsyn]
Enhanced [acty]
Phlebotomies [diap]
Blood Clotting [ortf]
Disturbance [qlco]
Heart failure [dsyn]
Serious [qlco]
Ventricular arrhythmias [patf]
Decade [qnco]
Seen [qlco]
Pulmonary Hypertension [dsyn]
pathophysiology [ftcn]
LED [mnob]
Introduction [hlca]
Group [idcn]
Drugs [phsu]
Prostacyclin [bacs, eico, phsu]
analogs [chvs]
Epoprostanol [bacs, eico, phsu]
Treprostinil [eico, phsu]
beraprost [eico, horm, phsu]
Phosphodiesterase Inhibitors [phsu]
sildenafil [orch, phsu]
tadalafil [orch, phsu]
Endothelin Receptor Antagonists [moft]
bosentan [orch, phsu]
ambrisentan [orch, phsu]
Nitric Oxide [bacs, inch, phsu]
Drugs [phsu]
Administered [ftcn]
Patients [podg]
III [inpr]
NYHA Class [fndg]
Successful [qlco]
Therapeutic Effect [hlca]
Patients [podg]
Eisenmenger Syndrome [cgab, dsyn]
Established [qlco]
Therapeutic [topp]
Effort [orgf]
Direct [qlco]
PREVENT [phsu]
Complications [patf]
Rule [idcn]
Agent [chvf]
Established [qlco]
Therapeutic Efficacy [qlco]
symptoms [ftcn]
Additional [ftcn]
disrupt [qlco]
Balance [orgf]
